Sepsis
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Clinical symptoms of septicemia, clinical outcome, and laboratory parameters of septicemia (C-reactive protein) were studied retrospectively in 66 patients with CONS septicemia.
|
10049985 |
1999 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Circulating concentrations of the sensitive inflammatory marker C-reactive protein (CRP) predict future cardiovascular events, and CRP is elevated during sepsis and inflammation, when vascular reactivity may be modulated.
|
15795363 |
2005 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Therefore, the diagnosis of sepsis is often based on the development of clinical signs, in combination with laboratory tests such as a rise in C-reactive protein (CRP).
|
19152691 |
2009 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
It more closely matches the criteria for usefulness than other candidate biomarkers such as C-reactive protein, which is rather a nonspecific marker of acute phase inflammation, and proinflammatory cytokines such as plasma IL-6 levels that are highly variable, cumbersome to measure, and lack specificity for systemic infection.
|
20236471 |
2010 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
To clarify the effect of these SNPs to CRP response in systemic infections, we compared genetic and clinical data on patients with Staphylococcus aureus bacteremia (SAB).
|
20552244 |
2010 |
Sepsis
|
0.300 |
Biomarker
|
disease |
RGD |
A model of experimental acute hematogenous pyelonephritis in the rat.
|
21797109 |
2011 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Development was unremarkable apart from an episode labeled as sepsis with documented hyperkalemia and elevated C-reactive protein at age 15 days.
|
22968487 |
2012 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Receiver operating characteristic curves showed that miR-15a had the highest area under the curve of 0.858 [95% confidence interval (CI) 0.800-0.916] for the diagnosis of sepsis compared with C reactive protein and procalcitonin with areas under the curve of 0.572 (95% CI 0.479-0.665; p=0.198) and 0.605 (95% CI 0.443-0.767; p=0.168), respectively.
|
22868808 |
2012 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
178 biomarkers are described in the literature--ranging from specimen cultures, which lack sensitivity and specificity for early diagnosis of sepsis, to biomarkers such as C-reactive protein, procalcitonin, and genetic biomarkers, which have their own limitations.
|
23108494 |
2013 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The area under the ROC curve for MMP-8 in the diagnosis of sepsis was 0.87 (95% CI 0.82-0.92), and that of CRP was 0.98 (0.94-0.998), whereas the area of MMP-9 in the detection of non-septic state was 0.73 (0.65-0.80), p < 0.0001 for all curves.
|
24833564 |
2014 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Genetic analysis found that individuals with the polymorphism of the FcγRIIa receptor that binds CRP poorly were also more likely to have decreased monocyte human leukocyte antigen DR and posttraumatic sepsis.
|
26496101 |
2015 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The area under ROC curve showed that the clinical accuracy of microRNA-25 for sepsis diagnosis was better than CRP and PCT (AUG=0.806, 0.676 and 0.726, P<0.05).The decrease in level of microRNA-25 was correlated with the severity of sepsis, SOFA score, CRP and PCT level, meanwhile, microRNA-25 level can be used for predicting the prognosis of patients, the patients with microRNA-25 level ≤0.492 had a lower 28 d survival rate.
|
26339334 |
2015 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The association of theses SNPs with the following parameters was evaluated: (1) the presence of sepsis; (2) severity and clinical outcomes; (3) APACHE II and SOFA scores; and (4) procalcitonin, C-reactive protein, tumor necrosis factor, lymphotoxin alpha, interleukin 1 beta and interleukin 10 plasma concentrations.
|
27592234 |
2016 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Six hours of polymicrobial sepsis elicited by cecal ligation and puncture (CLP) elevated serum C-reactive protein (CRP) (a bacteremia and sepsis marker) concentration in anesthetized and mechanically ventilated neonatal pigs.
|
27767365 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
• An elevated CRP concentration during the first postnatal week may be regarded as an expected finding in moderate and severe HIE and, in the overwhelming majority of cases, occurs secondary to hepatic hypoxia-ischemia in the absence of blood culture-positive sepsis.
|
28741035 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The induction of sepsis-associated blood C-reactive protein (CRP) and the pro-inflammatory cytokine IL-6 in response to MRSA infection was also suppressed in pigs that received Epi-1.
|
28177877 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
In conclusion, 1,25(OH)D but not 25(OH)D showed a minor discriminatory value for the prediction of bacteraemia that was inferior to CRP and PCT but both failed to predict sepsis and mortality in a prospective cohort of SIRS patients.
|
28079172 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The univariate analysis showed gastrointestinal hemorrhage (P < 0.001), hepatic encephalopathy (P < 0.001), albumin <30 g/L (P < 0.037), creatinine (Cr) >175 µmol/L (P < 0.001), cholinesterase(ChE) activity <3000 U/L (P = 0.019), white blood cell count ≥10 000 (109/L) (P = 0.018), neutrophils ≥80% (P = 0.018), C-reactive protein (CRP) ≥25 mg/L (P < 0.001), procalcitonin ≥1.0 ng/mL (P = 0.007), Child-Pugh class C (P < 0.001), septicemia (P < 0.001), pulmonary infection (P < 0.001),multi-site infection (P = 0.001), acute-on-chronic liver failure (ACLF) (P < 0.001), and advanced hepatocellular carcinoma (HCC) (P < 0.001).
|
28249358 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
It was found that a history of relapse, a refractory state of underlying disease, and high C-reactive protein concentrations at the beginning of fever were significant risk factors for mortality after developing sepsis.
|
26055687 |
2017 |
Sepsis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
To evaluate the PCT and CRP levels in 72 h at the onset of sepsis in GN and GP bacteremia.
|
27139197 |
2017 |
Sepsis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Serum sCD18 levels partitioned sepsis non-survivors into one group of 'high' sCD18 and low CRP and another group with 'low' sCD18 and high C-reactive protein.
|
28714582 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
The aim of our study is to explore the value of soluble cluster of differentiation 14 subtype (sCD14-ST) in whole blood for differential diagnosis of neonatal hematosepsis at an early stage, and used in evaluation of the severity about sepsis combined with acute physiology and chronic health evaluation II (APACHE-II) score, procalcitonin (PCT), C reactive protein (CRP), and leukocyte (WBC).In our cohort, all cases met the diagnostic criteria for hematosepsis specific for newborns.
|
28471985 |
2017 |
Sepsis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
<b>Conclusion</b> The CRP levels and heart rate both decreased, while the pH and base excess parameters of the blood gas analysis changed positively after pentoxifylline treatment in VLBW preterm neonates with nosocomial sepsis.
|
28196391 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
In both CKD1-4 and CKD5 patients, the predictive value of PCT for local infection is not as good as that of CRP, while it has a significant advantage in predicting sepsis.
|
28956241 |
2017 |
Sepsis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Based on the results of our meta-analysis, presepsin is a promising marker for diagnosis of sepsis as PCT or CRP, but its results should be interpreted more carefully and cautiously since too few studies were included and those studies had high heterogeneity between them.
|
28875483 |
2017 |